Any person, 16 years and over, presenting with a headache, excluding suspected stroke (FAST positive).
This protocol is intended to be used by registered and enrolled nurses within their scope of practice and as outlined in The Use of Emergency Care Assessment and Treatment Protocols (PD2024_011). Sections marked triangle or diamond indicate the need for additional prerequisite education prior to use. Check the medication table for dose adjustments and links to relevant reference texts.
If either of the following clinical signs are identified, escalate immediately as per local CERS protocol for advice regarding management. Do not give medication under this protocol. Rapidly complete assessment.
- Thunderclap headache (“worst ever” headache, severe pain, maximal pain within 1–2 minutes of onset)
- Headache associated with focal deficit, confusion, personality change, seizure, neck pain or fever
History prompts, signs and symptoms
These are not exhaustive lists. Maintain an open mind and be aware of cognitive bias.
History prompts
- Presenting complaint
- Onset of symptoms
- Pain assessment – PQRST
- Pre-hospital treatment
- Past admissions
- Past medical and surgical history, including headaches or migraines – is this similar or different to usual?
- Previous neurosurgery, VP shunt or recent trauma
- Current medications, including anticoagulant therapy
- Known allergies
- Vaccination status
Signs and symptoms
- Aura
- Photosensitivity
- Focal deficit
- Nausea
- Vomiting
Red flags
Recognise: identify indicators of actual or potential clinical severity and risk of deterioration.
Respond: carefully consider alternative ECAT protocol. Escalate as per clinical reasoning and local CERS protocol, and continue treatment.
Historical
- Frequent use, 8–10 times, of triptan medications over the past month
- History of cancer or neoplasm
- Previous neurosurgery or VP shunts
- History of trauma
- Potential poisoning
- Anticoagulant therapy
- Non-prescription drug or alcohol use
- Immunocompromised
- Over 50 years
- Pregnancy
- Post-partum
Clinical
- Altered level of consciousness
- Delirium or confusion
- Different to normal headache pattern or symptoms
- Severe neck stiffness with reduced mobility
- Sudden onset
- Non-blanching petechial rash
- Diplopia
- Fever
Remember adult at risk: patient or carer concern, frailty, multiple comorbidities or unplanned return.
Clinical assessment and specified intervention (A to G)
If the patient has any Yellow or Red Zone observations or additional criteria (as per the relevant NSW Standard Emergency Observation Chart), refer and escalate as per local CERS protocol and continue treatment.
Position
Assessment | Intervention |
---|---|
General appearance/first impressions | Position of comfort |
Airway
Assessment | Intervention |
---|---|
Patency of airway | Maintain airway patency Consider airway opening manoeuvres and positioning |
Breathing
Assessment | Intervention |
---|---|
Respiratory rate and effort Consider auscultation of chest (breath sounds) Oxygen saturations (SpO2) | Assist ventilation, as clinically indicated Consider oxygen if dyspnoeic, titrate oxygen to maintain SpO2 over 93% Patients at risk of hypercapnia, maintain SpO2 at 88–92% |
Circulation
Assessment | Intervention |
---|---|
Perfusion (capillary refill, skin warmth and colour) Pulse Blood pressure Cardiac rhythm | Assess circulation Attach cardiac monitor and complete 12 lead ECG if BP/HR are within the Yellow or Red Zones, or where clinically relevant, e.g. irregular pulse, palpitations, syncope, shock, respiratory compromise, cardiac history or clinical concern |
IVC and/or pathology | Insert IV cannula, if trained and clinically indicated If unable to obtain IV access, consider intraosseous, if trained |
Signs of shock: tachycardia and CRT 3 seconds and over and/or abnormal skin perfusion and/or hypotension | Headache with signs of shock and/or SBP less than 90 mmHg should be considered sepsis until proven otherwise. Switch to sepsis (suspected) protocol |
Disability
Assessment | Intervention |
---|---|
GCS, pupillary response and limb strength | Obtain baseline and repeat assessment as clinically indicated |
Pain | Assess pain. If indicated, give early analgesia as per analgesia section then resume A to G assessment |
Exposure
Assessment | Intervention |
---|---|
Temperature | If febrile, escalate care as per local CERS protocol |
Skin inspection, including posterior surfaces | If non-blanching rash is present, consider meningitis or encephalitis (suspected) protocol or sepsis (suspected) protocol |
Neck stiffness | Assess for neck stiffness (may indicate meningitis):
|
Fluids
Assessment | Intervention |
---|---|
Hydration status: last ate, drank, bowels opened, passed urine or vomited | Commence fluid balance chart, as required |
Nausea and/or vomiting | If present, see nausea and/or vomiting section |
Glucose
Assessment | Intervention |
---|---|
BGL | Measure BGL, if clinically indicated If less than 4 mmol/L, consider hypoglycaemia protocol |
Repeat and document assessment and observations to monitor responses to interventions, identify developing trends and clinical deterioration. Escalate care as required according to the local CERS protocol.
Focused assessment
Complete neurological focused assessment.
Precautions and notes
- A careful history and physical assessment, including precipitating factors, remain the most important part of identifying serious risk features for patients presenting with headaches.
- Opioids may alter a neurological assessment.
- Cluster headaches can have similar symptoms to more serious headaches due to their rapid onset. They can be differentiated by their transient nature, lasting a few hours and are often associated with tearing and rhinorrhoea.
- Headaches may be caused by medication overuse. Opioid analgesics, triptans, and ergots are frequently associated. Patients using these medications more than 10 days per month may be at risk.
Interventions and diagnostics
Specific treatment
- Some patients with cluster and migraine headaches can benefit from high-flow oxygen therapy. Start trial at 15 L/min via a non-rebreather, if not contraindicated.
- Consider comfort measures, such as darkened room.
Analgesia
If pain score 1–6 (mild–moderate), give:
- paracetamol 1000 mg orally once only
- and/or ibuprofen 400 mg orally once only.
If severe pain present, give analgesia and escalate as per local CERS protocol.
Nausea and/or vomiting
If nausea and/or vomiting is present, give:
- metoclopramide 10 mg orally or IV/IM once only (over 20 years only)
- or ondansetron 4 mg orally or IV/IM. If symptoms persist after 60 minutes, repeat once, maximum dose 8 mg
- or prochlorperazine 5 mg orally once only or 12.5 mg IV/IM once only
Choice of antiemetic should be determined by cause of symptoms.
Radiology
Radiology will depend on the working diagnosis. It needs to be requested by a medical or nurse practitioner. If there is concern for urgent radiology, escalate as per local CERS protocol.
Pathology
- FBC, UEC
- Pregnant: urinalysis, check for proteinuria
- Temp less than 35°C, or 38.5°C and over: take two sets of blood cultures from two separate sites
- Potential carboxyhaemoglobin poisoning: ABG (if trained) or VBG to assess for carboxyhaemoglobin (COHb) and lactate
- Warfarinised: INR
Medications
The shaded sections in this protocol are only to be used by registered nurses who have completed the required education.
Drag the table right to view more columns or turn your phone to landscape
Drug | Dose | Route | Frequency |
---|---|---|---|
Ibuprofen H, R | 400 mg | Oral | Pain score 1–10
Once only |
Over 20 years: | Oral/IV/IM | Once only | |
4 mg Maximum dose 8 mg | Oral/IV/IM | Repeat once if required after 60 minutes | |
Oxygen | 2–15 L/min, device dependent | Inhalation | Continuous |
1000 mg | Oral | Pain score 1–10 Once only | |
5 mg | Oral | Once only | |
OR | |||
12.5 mg | IV/IM | Once only |
Medications with contraindications or requiring dose adjustment are marked:
- H for patients with known hepatic impairment
- R for patients with known renal impairment.
Escalate to medical or nurse practitioner.
References
- Schwedt T, Garza I. Acute treatment of migraine in adults. UpToDate: Wolters Kluwer; 2022 [cited 15 Feb 2023]. Available from: https://www.uptodate.com.acs.hcn.com.au/contents/acute-treatment-of-migraine-in-adults
- Neblett M. Assessment of acute headache in adults. BMJ Best Practice BMJ Publishing Group, ; 2023 [cited 14 Feb 2023]. Available from: https://bestpractice.bmj.com.acs.hcn.com.au/topics/en-gb/9?topicfile=migraine
- NSW Health. Australian Medicines Handbook. Australia: Australian Government, NSW; 2022 [cited 13 Apr 2022]. Available from: https://amhonline.amh.net.au.acs.hcn.com.au/
- Long BJ, Koyfman A. Benign Headache Management in the Emergency Department. J Emerg Med. 2018 Apr;54(4):458-68. DOI: 10.1016/j.jemermed.2017.12.023
- MIMS Australia. Clinical Resources. Australia: MIMS Australia Pty Ltd; 2022 [cited 2 Feb 2023]. Available from: https://www.mimsonline.com.au.acs.hcn.com.au/Search/Search.aspx
- Cuttrer M, Wippold F, Edlow J. Evaluation of the adult with nontraumatic headache in the emergency department. UpToDate: Wolters Kluwer; 2022 [cited 15 Feb 2023]. Available from: https://www.uptodate.com/contents/evaluation-of-the-adult-with-nontraumatic-headache-in-the-emergency-department
- NSW Emergency Care Institute. Headache. Australia: Agency for Clinical Innovation; 2018 [cited 15 Feb 2023]. Available from: https://aci.health.nsw.gov.au/networks/eci/clinical/tools/neurology/headache
- Oliver N. Migraine Management in the Emergency Department. J Emerg Nurs. 2020 Jul;46(4):518-23. DOI: 10.1016/j.jen.2020.04.002
- Bennett MH, French C, Schnabel A, et al. Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache. Cochrane Database of Systematic Reviews. 2015 (12). Available from: https://doi.org//10.1002/14651858.CD005219.pub3
- Stephens G, Derry S, Moore RA. Paracetamol (acetaminophen) for acute treatment of episodic tension‐type headache in adults. Cochrane Database of Systematic Reviews. 2016 (6). Available from: https://doi.org//10.1002/14651858.CD011889.pub2
- NSW Emergency Care Institute. Rapid Reference Guide to Serious Headaches. Australia: Agency for Clinical Innovation; 2018 [cited 15 Feb 2023]. Available from: https://aci.health.nsw.gov.au/networks/eci/clinical/tools/neurology/headache
- Beasley R, Chien J, Douglas J, et al. Thoracic Society of Australia and New Zealand oxygen guidelines for acute oxygen use in adults: 'Swimming between the flags'. Respirology. 2015 Nov;20(8):1182-91. DOI: 10.1111/resp.12620
- Law S, Derry S, Moore RA. Triptans for acute cluster headache. Cochrane Database of Systematic Reviews. 2013 (7). Available from: https://doi.org//10.1002/14651858.CD008042.pub3
Evidence informed |
Information was drawn from evidence-based guidelines and a review of latest available research. For more information, see the development process. |
Collaboration |
This protocol was developed by the ECAT Working Group, led by the Agency for Clinical Innovation. The group involved expert medical, nursing and allied health representatives from local health districts across NSW. Consensus was reached on all recommendations included within this protocol. |
Currency | Due for review: Jan 2026. Based on a regular review cycle. |
Feedback | Email ACI-ECIs@health.nsw.gov.au |
Accessed from the Emergency Care Institute website at https://aci.health.nsw.gov.au/ecat/adult/headache